Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide
- 19 September 2015
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 39 (11) , 1292-1298
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenitaBlood, 2012
- Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndromeBlood, 2011
- Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cellsProceedings of the National Academy of Sciences, 2011
- Identification of CD133−/Telomeraselow Progenitor Cells in Glioblastoma-Derived Cancer Stem Cell LinesCellular and Molecular Neurobiology, 2010
- Persistent Malignant Stem Cells in del(5q) Myelodysplasia in RemissionNew England Journal of Medicine, 2010
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotypeNature Medicine, 2009
- Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem CellsStem Cells, 2007
- High-throughput telomere length quantification by FISH and its application to human population studiesProceedings of the National Academy of Sciences, 2007
- Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)–negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISHBlood, 2005
- Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31Leukemia, 2003